Skip to content
stoqly

Maxlinear, Inc

MXL Nasdaq Semiconductors & Related Devices Financials FY2016–FY2025

Revenue Total sales reported in the income statement.
$468M
29.7% vs prior year
Operating margin Operating income as a share of revenue.
−27.1%
34.8 pts
Net income Profit after all expenses, interest and tax.
−$137M
Free cash flow Cash from operations minus capital spending.
$7.0M
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
−19.9%
13.9 pts
Market cap Last close times the latest diluted share count, so it is approximate.
—
P/E Last close divided by diluted earnings per share over the last four quarters.
—
On −$0.37 EPS (TTM)

What Maxlinear, Inc does

No business description yet.

Legal name
MAXLINEAR, INC
Fiscal year ends
December 31, 2025
Latest annual report
10-K · Jan 29, 2026
Accession · CIK
0001288469-26-000011
0001288469

Revenue and margins

Maxlinear, Inc had $468M of revenue in fiscal 2025, up 29.7% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was $7.0M in fiscal 2025, 1.5% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Maxlinear, Inc returned $20.0M to shareholders in fiscal 2025, 285% of free cash flow. The diluted share count rose 3.6%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Balance sheet

Cash, debt and the ratios that show how comfortably Maxlinear, Inc can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $131M$206M$187M$119M$72.8M
Debt incl. finance leases $306M$122M$122M$123M$124M
Net debt / EBITDA 1.1x−0.3x−1.9x——
Debt / equity 0.6x0.2x0.2x0.2x0.3x
Interest coverage 5.0x18.5x−3.6x−20.5x−12.6x
Current ratio 1.9x1.7x2.2x1.8x1.3x
Quick ratio 1.3x1.2x1.7x1.3x0.9x
Total assets $1.1B$1.2B$1.1B$865M$796M
Total liabilities $561M$504M$394M$348M$345M
Shareholders' equity $489M$676M$686M$516M$452M
Net debt (− = net cash) $176M−$84.1M−$64.9M$4.4M$50.8M

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$0.0M

0 insiders

Of sales under plans

—

$0.0M

No open-market insider trades in the last 12 months.

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Net income is positive ✓ ✕ ✕ ✕ ✕ ✓ ✓ ✕ ✕ ✕
Cash from operations is positive ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✕ ✓
Return on assets rose — ✕ ✕ ✓ ✕ ✓ ✓ ✕ ✕ ✓
Cash from operations exceeds net income ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Debt fell relative to assets — ✕ ✓ ✓ ✕ ✓ ✓ ✕ ✕ ✕
Current ratio rose — ✕ ✕ ✓ ✕ ✓ ✕ ✓ ✕ ✕
Share count didn't rise — ✓ ✕ ✕ ✕ ✕ ✕ ✓ ✕ ✕
Gross margin rose — ✕ ✓ ✕ ✕ ✓ ✓ ✕ ✕ ✓
Revenue rose relative to assets — ✕ ✓ ✕ ✓ ✓ ✓ ✕ ✕ ✓
F-score — / 33 / 95 / 95 / 93 / 98 / 97 / 94 / 91 / 95 / 9
Accruals ratio −13.3%−13.5%−16.4%−13.6%−19.9%−12.2%−23.6%−10.3%−20.6%−18.8%
Altman Z'' 8.271.471.611.830.132.033.552.85−0.48−1.22

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $388M $420M $385M $317M $479M $892M $1.1B $693M $361M $468M
Gross profit $230M $208M $209M $168M $213M $496M $650M $386M $195M $266M
Research and development $97.7M $112M $120M $98.3M $180M $278M $296M $270M $225M $209M
Operating income $63.1M −$21.7M −$19.1M −$22.1M −$101M $65.2M $180M −$38.2M −$223M −$127M
Interest expense $0.1M $10.4M $14.3M $11.1M $13.0M $13.0M $9.8M $10.7M $10.9M $10.1M
Pretax income $63.7M −$34.0M −$32.9M −$32.5M −$115M $47.9M $174M −$63.8M −$239M −$141M
Income tax $2.4M −$24.8M −$6.7M −$12.6M −$16.3M $5.9M $49.2M $9.3M $6.5M −$4.2M
Net income $61.3M −$9.2M −$26.2M −$19.9M −$98.6M $42.0M $125M −$73.1M −$245M −$137M
Diluted EPS $0.91 −$0.14 −$0.38 −$0.28 −$1.35 $0.53 $1.55 −$0.91 −$2.93 −$1.58
Diluted shares 0.07B 0.07B 0.07B 0.07B 0.07B 0.08B 0.08B 0.08B 0.08B 0.09B
Cash flow
Cash from operations $117M $75.1M $103M $78.3M $73.6M $168M $389M $43.4M −$45.3M $19.6M
Capital expenditure $8.5M $7.5M $7.8M $6.9M $12.5M $39.2M $41.3M $13.5M $17.7M $12.6M
Free cash flow $109M $67.6M $94.9M $71.5M $61.1M $129M $347M $29.9M −$63.0M $7.0M
Depreciation and amortization $26.7M $66.7M $79.0M $66.4M $76.5M $91.8M $80.7M $71.5M $54.1M $44.0M
Stock-based compensation $21.8M $32.7M $31.7M $32.1M $47.6M $59.4M $81.7M $55.2M $66.0M $77.1M
Acquisitions $101M $473M $0.0M $0.0M $160M $40.0M $0.0M $13.3M $0.0M $0.0M
Share buybacks $0.0M $0.3M $0.0M $0.0M $0.0M $23.5M $31.5M $0.0M $0.0M $20.0M
Dividends and buybacks $0.0M $0.3M $0.0M $0.0M $0.0M $23.5M $31.5M $0.0M $0.0M $20.0M
Balance sheet
Cash and short-term investments $81.1M $71.9M $73.1M $92.7M $149M $131M $206M $187M $119M $72.8M
Total debt $0.0M $348M $256M $207M $370M $306M $122M $122M $123M $124M
Current assets $213M $201M $185M $182M $362M $404M $563M $488M $323M $249M
Current liabilities $54.5M $76.4M $75.3M $66.6M $234M $207M $341M $222M $182M $186M
Inventory $26.6M $53.4M $41.7M $31.5M $97.8M $132M $161M $99.9M $90.3M $78.1M
Property and equipment, net $20.5M $22.7M $18.4M $16.6M $39.5M $60.9M $79.0M $66.4M $59.3M $48.9M
Goodwill $76.0M $238M $238M $238M $303M $307M $307M $319M $319M $319M
Intangible assets $104M $315M $245M $188M $207M $153M $109M $73.6M $55.0M $48.9M
Total assets $423M $825M $744M $706M $1.0B $1.1B $1.2B $1.1B $865M $796M
Total liabilities $70.2M $437M $344M $291M $631M $561M $504M $394M $348M $345M
Preferred stock $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M
Shareholders' equity $352M $387M $400M $415M $391M $489M $676M $686M $516M $452M
Margins
Gross margin 59.3% 49.5% 54.2% 52.9% 44.5% 55.6% 58.0% 55.6% 54.0% 56.8%
Operating margin 16.3% −5.2% −5.0% −7.0% −21.1% 7.3% 16.1% −5.5% −62.0% −27.1%
EBITDA margin 23.1% 10.7% 15.6% 14.0% −5.1% 17.6% 23.3% 4.8% −46.9% −17.7%
Net margin 15.8% −2.2% −6.8% −6.3% −20.6% 4.7% 11.2% −10.6% −68.0% −29.2%
FCF margin 28.1% 16.1% 24.6% 22.5% 12.8% 14.5% 31.0% 4.3% −17.5% 1.5%
Returns
Return on capital 22.4% −2.6% −2.6% −3.3% −13.1% 8.6% 21.8% −4.9% −33.9% −19.9%
Return on capital employed 17.1% −2.9% −2.9% −3.5% −12.8% 7.7% 21.5% −4.5% −32.7% −20.8%
Return on equity 17.4% −2.5% −6.7% −4.9% −24.5% 9.5% 21.5% −10.7% −40.8% −28.2%
Return on assets 14.5% −1.5% −3.3% −2.7% −11.4% 4.0% 11.2% −6.5% −25.2% −16.5%
Return on tangible equity 35.6% — — — — 139.9% 48.0% −24.9% −171.8% −161.9%
Growth
Revenue growth — 8.4% −8.4% −17.6% 50.9% 86.5% 25.5% −38.1% −48.0% 29.7%
Net income growth — −115.0% — — — — 197.9% −158.5% — —
EPS growth — −115.4% — — — — 192.5% −158.7% — —
FCF growth — −37.9% 40.3% −24.7% −14.5% 111.2% 169.2% −91.4% −310.5% —
Share count change — −2.1% 3.4% 3.7% 3.0% 9.0% 1.5% −0.2% 3.6% 3.6%
Financial health
Net debt / EBITDA −0.9x 6.1x 3.0x 2.6x — 1.1x −0.3x −1.9x — —
Debt / equity 0.0x 0.9x 0.6x 0.5x 0.9x 0.6x 0.2x 0.2x 0.2x 0.3x
Interest coverage 606.3x −2.1x −1.3x −2.0x −7.8x 5.0x 18.5x −3.6x −20.5x −12.6x
Current ratio 3.9x 2.6x 2.5x 2.7x 1.5x 1.9x 1.7x 2.2x 1.8x 1.3x
Quick ratio 3.4x 1.9x 1.9x 2.3x 1.1x 1.3x 1.2x 1.7x 1.3x 0.9x
Capital allocation
Capex / revenue 2.2% 1.8% 2.0% 2.2% 2.6% 4.4% 3.7% 1.9% 4.9% 2.7%
Stock comp / revenue 5.6% 7.8% 8.2% 10.1% 9.9% 6.7% 7.3% 8.0% 18.3% 16.5%
Payouts / FCF 0.0% 0.5% 0.0% 0.0% 0.0% 18.2% 9.1% 0.0% — 284.9%
Quality scores
Piotroski F-score — 3.0 5.0 5.0 3.0 8.0 7.0 4.0 1.0 5.0
Altman Z'' 8.3 1.5 1.6 1.8 0.1 2.0 3.5 2.8 −0.5 −1.2
Accruals ratio −13.3% −13.5% −16.4% −13.6% −19.9% −12.2% −23.6% −10.3% −20.6% −18.8%

Source: SEC EDGAR XBRL filings (CIK 0001288469). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move · ↵ to open